In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Evidence to inform practice: promising avenues and dead ends
Session

Event : ESC Congress 2018

Topic : e-Cardiology / Digital Health

  • Session type : Symposium
  • Date : 28 August 2018
  • Time : 14:30 - 15:45

5 presentations in this session

Evidence to inform practice: promising avenues and dead ends - Panel.

Event : ESC Congress 2018

  • Session : Evidence to inform practice: promising avenues and dead ends

Introduction.

Event : ESC Congress 2018

  • Session : Evidence to inform practice: promising avenues and dead ends
  • Speaker : P Juni (Toronto,CA)

Large single trials: dealing with success and failure.

Event : ESC Congress 2018

  • Session : Evidence to inform practice: promising avenues and dead ends
  • Speaker : SJ Pocock (London,GB)

Observational studies to inform practice guidelines? .

Event : ESC Congress 2018

  • Session : Evidence to inform practice: promising avenues and dead ends
  • Speaker : C Baigent (Oxford,GB)

When meta-analyses fail.

Event : ESC Congress 2018

  • Session : Evidence to inform practice: promising avenues and dead ends
  • Speaker : P Juni (Toronto,CA)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are